1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105–1187.
2. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000;36:894–900.
3. Zhong GW, Li W, Luo YH, Chen GL, Yi ZJ, Chen ZQ, et al. Effect of calming the liver and suppressing the hyperactive yang drugs on lymphocyte protein in hypertension patients with hyperactivity of liver yang. J Cent South Univ (Med Sci, Chin) 2008;33:1005–1011.
4. Zhong GW, Luo YH, Xiang LL, Xie Y, Xie QY, Li YH, et al. Clinical efficacy study on calming liver and restraining yang formula in treating patients with mild or moderate degree of essential hypertension. China J Chin Mater Med (Chin) 2010;35:776–781.
5. Guan DM, Qi YQ, Wang XH. Study of evaluating effects of decreasing blood pressure drug with trough peak ratio. J Harbin Med Univ (Chin) 2002;36:466–467.